Key result
Genetically proxied aspirin use is linked to ~96% higher risk of atrial fibrillation.
Why the study?
The causal relationship between aspirin use and the risk of atrial fibrillation remained uncertain.
Does genetically proxied aspirin use increase the risk of atrial fibrillation in individuals of European ancestry?
Observational (n=1,030,836)
Does genetically proxied aspirin use increase the risk of atrial fibrillation in individuals of European ancestry?
Answers are grounded in this paper and cite their sources.
This two-sample Mendelian randomization study provides the first genetic evidence suggesting a potential causal association between aspirin use and an increased risk of developing atrial fibrillation in a European population.
Purpose The relationship between aspirin use and atrial fibrillation (AF) remains uncertain. This study is aimed at determining the causal association of aspirin use and AF risk by Mendelian randomization (MR) analysis. Methods Single nucleotide polymorphisms (SNPs) for aspirin use and AF were obtained from genome‐wide association studies (GWAS). The inverse variance weighted (IVW) was used as the primary MR analysis method. In addition, I performed Cochran′s Q, MR‐Egger′s intercept, leave‐one‐out, MR‐PRESSO, and Radial MR to evaluate heterogeneity, horizontal pleiotropy, sensitivity, and reliability of the results. Results Finally, 42 independent SNPs were selected as instrumental variables (IVs). The findings revealed that genetically proxied aspirin use elevated AF risk (odds ratio [OR] IVW = 1.96 [95% confidence interval (CI) 1.10, 3.47], p = 0.021) in European population. The subsequent analysis confirmed the validity of the primary MR results. Cochran′s Q test ( p > 0.05), MR‐Egger′s intercept ( p > 0.05), MR‐PRESSO global test ( p > 0.05), and Radial MR ( p > 0.05). Conclusion This MR study provides evidence suggesting a potential causal association between aspirin use and an increased risk of AF. However, given the inherent limitations of the MR design, these findings should be interpreted with caution. Future large‐scale randomized controlled trials (RCTs) with long‐term follow‐up are warranted to confirm and extend these observations.
No takes yet. Share an insight, caveat, or question.
Gang Fan (2026) conducted an observational in Atrial fibrillation (n=1,030,836). Genetically proxied aspirin use (42 independent SNPs) vs. Non-use / lower genetic liability to aspirin use was evaluated on Atrial fibrillation incidence (inverse variance weighted method) (OR 1.96, 95% CI 1.10-3.47, p=0.021). Genetically proxied aspirin use was associated with an elevated risk of atrial fibrillation in individuals of European ancestry.
Synapse has enriched 10 related papers. Consider them for comparative context: